Alupresssp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-05-09
Share capital
5 000,00 PLN
Registered address
Łódź, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2023 – the filing deadline has passed. 5 of 5 financial statements were filed late (the longest delay 684 days for 2020).

  • 2023not filed
  • 202201/09/2023
  • 202101/09/2023
  • 202030/08/2023
  • 201930/12/2020
  • 201818/03/2020
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2022.

Results vs industry

Revenue
This companyUSD 12.30kMedianUSD 1.06mAverageUSD 22.41m
Net profit
This companyUSD 12.19kMedianUSD 37.20kAverageUSD 879.46k
Operating costs
This companyUSD 112.16MedianUSD 921.66kAverageUSD 21.08m
Assets
This companyUSD 250.22kMedianUSD 609.79kAverageUSD 11.85m

Authorized Representatives

Claudio Montini – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Claudio Montiniage 52
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2022-08-29.

No bank accounts reported to the VAT Taxpayer Register.

Debt

31 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Oct 14, 2025
Discontinued enforcement proceedings
Closed
Oct 14, 2025
Discontinued enforcement proceedings
Closed
Oct 14, 2025
Discontinued enforcement proceedings
Closed
Oct 14, 2025
Discontinued enforcement proceedings
Closed
Oct 14, 2025
Discontinued enforcement proceedings
Closed

Public aid

6 public aid cases recorded, with a total value of $26,721.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,495
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,161
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,279

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Novama CloudS.A.
Euroleki Gksp. z o.o. + limited partnership
Ana-Medsp. z o.o.
TDFS.A.
Orthoactivesp. z o.o.
CanpolandS.A.
Geneco Groupsp. z o.o.
Novaova Sosnowski Wadowskisp. k.
Endolink PharmaS.A.
Novaovasp. z o.o.

Change history

DateEvent
2022-06-07Address change
2020-12-11PKD change
2017-03-06Address change
2015-05-18PKD change
2014-05-09Entered in the register

FAQ

Last updated: 2026-10-07